Biorestorative Therapies Inc (BRTX) 6.0000

New Post Public Reply Private Reply Replies (0) Message Board

Oct 11, 2015 at 6:04 AM

Biorestorative Therapies Inc (BRTX) 6.0000 $BRTX

BioRestorative Therapies Announces Research Collaboration With University of Pennsylvania
GlobeNewswire - Tue Sep 15, 7:00AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCQB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has entered into a one-year research collaboration agreement with the University of Pennsylvania. The research is intended to develop the Company's ThermoStem(R) Program by advancing the understanding of brown adipose ("brown fat"

biology and its role in metabolic disorders. Brown fat is recognized as playing a role in caloric burning, as well as potentially regulating glucose and lipid levels.

BioRestorative Therapies to Evaluate Cell Delivery Technology to Advance Metabolic Program Towards Human Trials
GlobeNewswire - Mon Jul 20, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or "the Company"

(OTCQB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has begun to evaluate encapsulation technology for potential use as a cell delivery system for the Company's metabolic program.

BioRestorative Therapies to reverse split stock 1:20 effective tomorrow
Seeking Alpha - at Seeking Alpha - Mon Jul 06, 4:18PM CDT

BioRestorative Therapies, Inc. Announces Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ Capital Market
GlobeNewswire - Mon Jul 06, 4:00PM CDT
BioRestorative Therapies, Inc. ("BRTX" or the "Company"

(OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced a 1-for-20 reverse split of its common stock in preparation for the planned listing of its common stock on the NASDAQ Capital Market. The reverse stock split will become effective on Tuesday, July 7, 2015 and the Company's common stock will begin trading on a split-adjusted basis under the temporary ticker symbol "BRTXD." This temporary ticker symbol will remain in effect for 20 days, at which point it will revert back to "BRTX." The new CUSIP number is 090655408.

BioRestorative Therapies Announces Conversion of $5.15 Million of Debt to Equity
GlobeNewswire - Tue Jun 02, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT or "the Company"

(OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced the conversion of $5.15 million of debt into common shares and warrants.

BioRestorative Therapies to Present ThermoStem(R) Data at 21st Annual Meeting of the International Society for Cellular Therapy
GlobeNewswire - Wed May 27, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT" or "the Company"

(OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Francisco Silva, Vice President of Research and Development and Chief Scientist, will present data from the Company's ongoing programs to develop a human-derived 3D brown adipose tissue construct at the 21 Annual Meeting of the International Society for Cellular Therapy (ISCT). The meeting will take place in Las Vegas from May 27 through May 30.

BioRestorative Therapies to Present at the 2015 Marcum MicroCap Conference in New York City
GlobeNewswire - Tue May 26, 7:30AM CDT
BioRestorative Therapies, Inc. ("BRT or "the Company"

(OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Mark Weinreb, the company's CEO, will present a company overview at the 2015 Marcum MicroCap Conference on Thursday, May 28 at 2:00 pm in the Alvin room.

BioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York
Business Wire - Tue Apr 14, 6:45AM CDT
BioRestorative Therapies, Inc. ("BRT" or "the Company"

(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announced today that the Company has relocated its corporate, administrative and laboratory operations to Melville, Long Island, New York.

BioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors
Business Wire - Wed Apr 08, 7:52AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCBB:BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, today announced the appointment of Charles S. Ryan, J.D., Ph.D. to its Board of Directors.

BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Business Wire - Tue Feb 17, 7:02AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Edward Field has been appointed as President of the Company's brtxDISC(TM) Division.

BioRestorative Therapies, Inc. to Present at Inaugural Innovations Conference
Business Wire - Thu Feb 05, 7:27AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCBB: BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, announced that it will be presenting at The Brewer Group's ("TBG"

inaugural Innovations Conference in Miami on Monday, February 9, 2015 at The Mondrian South Beach.

BioRestorative Therapies Appoints Dr. Joy Cavagnaro to Scientific Advisory Board
Business Wire - Mon Feb 02, 6:50AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Joy Cavagnaro, Ph.D., DABT, RAC, has been appointed as a member of the Company's Scientific Advisory Board.

BioRestorative Therapies Reports Successful Meeting with FDA
Business Wire - Mon Jan 12, 7:09AM CST
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCBB: BRTX), a life sciences company focused on adult stem cell-based products and therapies for various personal medical applications, announced that it has had a successful pre-investigational new drug (Pre-IND) meeting with the U.S. Food and Drug Administration (the "FDA"

concerning its lead therapeutic product, brtxDISC(TM), to be used in a non-surgical treatment for chronic lumbar disc disease.

BioRestorative Therapies Schedules Pre-IND Meeting with FDA
Business Wire - Mon Nov 24, 7:30AM CST
--Clinical Development Meeting with FDA

BioRestorative Therapies Engages Access BIO to Support Advancement of brtxDISC(TM) Program into Clinical Studies
Business Wire - Thu Oct 09, 8:04AM CDT
BioRestorative Therapies, Inc. ("BRT" or the "Company"

(OTCBB: BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, announces the engagement of Access BIO, L.C. to provide strategic preclinical and regulatory consulting services related to the Company's brtxDISC(TM) program. Initially Access BIO will help the Company prepare for pre-Investigational New Drug (IND) and IND meetings with the U.S. Food and Drug Administration (FDA). This represents the next stage in advancing the Company's brtxDISC(TM) procedure into the clinic.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EQT Acquires Range Resources: Redefining Gas Markets

A New Chapter in Natural Gas Who would have thought? EQT Corporation, that sturdy old veteran in the natural gas game, finally made its move and snatched up Range Resources, sprinting right out of left field. This merger isn't just about two companies shaking hands; it's about rewriting the entire narrative of America's natural gas landscape. With this acquisition, EQT's...

Ericsson Executes Bold Share Buyback Plan in Oct.

Ericsson Kicks Off October with Major Share Repurchases Ericsson's taking bold steps in consolidating shareholder value, and folks, this ain't your run-of-the-mill stock-in-the-drawer move. Between October 19 and 23, 2026, Ericsson picked up 500,000 of its own Class B shares. Yep, you heard right—half a million shares just like that, with a neat price tag rounding out...

WuXi AppTec Boosts Guidance Amid Strong CRDMO Growth

Unpacking WuXi AppTec's Latest Performance Boost WuXi AppTec, the pharmaceutical giant, isn't just coasting on its past successes. The way they're riding the contract research, development, and manufacturing (CRDMO) train straight through Q1 to Q3 of 2026 shows they're not just here for show. They've hiked up the stakes with strong metrics across the board, warranting a...

Shenzhen Hosts FDI Moot: A Key Milestone for Arbitration

Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...

Metallium's U.S. Supply Chain Ambitions Hinge on Traxys MOU

Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...

GrOwnValve's Personalized Valves Pass Safety Milestone

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Duke Energy's Battle Against Energy Vampires Heats Up

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

New Drug Revolutionizes Endometrial Cancer Treatment

A New Dawn for Endometrial Cancer Treatment Alright, every once in a while, something shakes up the world of oncology. And that's exactly what's happening with sacituzumab tirumotecan, or sac-TMT if you want to save your breath. This new drug is stepping up as a future star in the fight against endometrial cancer, according to an eye-popping international study led by NYU...

FL Technics Indonesia Expands with EASA Certification

Bali's Skies Just Got a Major Upgrade Picture this: You've got a sprawling 17,000 square meter facility sitting pretty at I Gusti Ngurah Rai International Airport, nestled in the paradise locale of Bali. What's next? It's now flexing some serious muscles with its newfound EASA Part-145 certification, allowing it to tackle aircraft registered in the European Union. This is...

Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...